Replimune (REPL) Common Equity (2018 - 2026)
Replimune (REPL) reported Common Equity of $204.78 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 22.2% from $263.34 million a year earlier but up 93.8% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Common Equity (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Replimune posted Common Equity of $166.16 million, down 60.0% from FY2025.
- Common Equity has a five-year compound annual growth rate of -19.7% (FY2021 to FY2026).
- By fiscal year, Common Equity came in at $415.84 million in FY2025 (+11.0%), $374.51 million in FY2024 (-32.6%), $555.29 million in FY2023 (+35.0%) and $411.23 million in FY2022 (-17.5%).
- Five-year quarterly Common Equity spans a low of $105.65 million in fiscal Q1 2027 and a high of $595.35 million in fiscal Q3 2023.
- Year over year, Common Equity has now declined in each of the last six quarters, with an average decline of 29.2% over the last eight quarters.
- The high point for year-over-year Common Equity in five years was fiscal Q3 2023 (growth of 36.1%); the low point was fiscal Q1 2027 (a decline of 68.6%).
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $105.65 million (Q1 2027), $166.16 million (Q4 2026) and $210.54 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Replimune | 2.40 Bn | 1.35 Bn | - | 204.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 204.78 Mn |
| Jun 30, 2026 | 105.65 Mn |
| Mar 31, 2026 | 166.16 Mn |
| Dec 31, 2025 | 210.54 Mn |
| Sep 30, 2025 | 263.34 Mn |
| Jun 30, 2025 | 336.72 Mn |
| Mar 31, 2025 | 415.84 Mn |
| Dec 31, 2024 | 482.37 Mn |
| Sep 30, 2024 | 381.46 Mn |
| Jun 30, 2024 | 426.45 Mn |
| Mar 31, 2024 | 374.51 Mn |
| Dec 31, 2023 | 421.54 Mn |
| Sep 30, 2023 | 465.17 Mn |
| Jun 30, 2023 | 514.03 Mn |
| Mar 31, 2023 | 555.29 Mn |
| Dec 31, 2022 | 595.35 Mn |
| Sep 30, 2022 | 384.07 Mn |
| Jun 30, 2022 | 410.26 Mn |
| Mar 31, 2022 | 411.23 Mn |
| Dec 31, 2021 | 437.51 Mn |
API Access
Replimune Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();